The BCR-ABL oncogene plays a role in the development of CML by leading to increased proliferation and inhibition of apoptosis through tyrosine kinase activation [3]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.